Today

Agents

Chat

Arena

Discover

More

App

MariMed Q2 Adjusted EBITDA USD 3.9 Million - MRMD News | Rallies

MariMed Q2 Adjusted EBITDA USD 3.9 Million

MRMD•2026-08-12

Q2 financial metrics

Aug. 12 (Reuters) - MariMed Q2 revenue was USD 41.9 million.

Q2 adjusted net income: USD -2.4 million
Q2 adjusted EBITDA margin: 9%
Q2 net income: USD -3.6 million
Q2 gross margin: 39%
Q2 adjusted gross margin: 40%

Related News

Workhorse Group Increases Credit Agreement Commitment To $40 Million On August 11, 2026

WKHS•2026-08-12

BeOne Medicines CEO John Oyler sells USD 67.94 million in ADSs (common shares)

ONC•2026-08-12

Cerence EVP Chief Admin Officer Jennifer Salinas disposes of 25,998 common shares worth $229,514.16

CRNC•2026-08-12

Cabot Corporation Files Pricing Term Sheet For $350 Million 4.950% Senior Notes Due 2029

CBT•2026-08-12

Artivion SVP, General Counsel Jean F. Holloway disposes of 977 common shares for $27,834.73

AORT•2026-08-12